Patents by Inventor Stephen Wank

Stephen Wank has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8853356
    Abstract: This invention pertains to the discovery that pentagastrin, when administered in conjunction with a proton pump inhibitor (PPI) is synergistic with the PPI and significantly increases the efficacy of the PPI in reducing/mitigating excess gastric acid secretion.
    Type: Grant
    Filed: July 30, 2007
    Date of Patent: October 7, 2014
    Assignee: The Regents of the University of California
    Inventors: Joseph R. Pisegna, Stephen Wank
  • Patent number: 7807623
    Abstract: This invention pertains to the discovery administration of a CCK receptor agonist can increase urinary sodium excretion and/or free water excretion in a mammal. CCK receptor agonist can thereby be used in the treatment of conditions such high blood pressure, fluid retention associated with heart failure, fluid retention associated with acute or chronic kidney failure, fluid retention associated with cirrhosis, fluid retention associated with liver failure, calcium kidney stones, nephrogenic diabetes insipidus, and renal tubular acidosis.
    Type: Grant
    Filed: December 8, 2006
    Date of Patent: October 5, 2010
    Assignee: The Regents of the University of California
    Inventors: Joseph R. Pisegna, Stephen Wank
  • Publication number: 20080045462
    Abstract: This invention pertains to the discovery that pentagastrin, when administered in conjunction with a proton pump inhibitor (PPI) is synergistic with the PPI and significantly increases the efficacy of the PPI in reducing/mitigating excess gastric acid secretion.
    Type: Application
    Filed: July 30, 2007
    Publication date: February 21, 2008
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Joseph Pisegna, Stephen Wank
  • Publication number: 20070207959
    Abstract: This invention pertains to the discovery that pentagastrin, when administered in conjunction with a proton pump inhibitor (PPI) is synergistic with the PPI and significantly increases the efficacy of the PPI in reducing/mitigating excess gastric acid secretion.
    Type: Application
    Filed: December 8, 2006
    Publication date: September 6, 2007
    Inventors: JOSEPH PISEGNA, STEPHEN WANK